SYSTEMATIC REVIEW ON COST AND HEALTHCARE RESOURCE UTILIZATION IN IMMUNOGLOBULIN A NEPHROPATHY (IGAN)

被引：0
|
作者：
Doherty, J. [1 ]
George, K. [2 ]
Akkapantula, S. [2 ]
Kolli, N. R. [2 ]
Pannagl, K. [3 ]
机构：
[1] Novartis Pharma AG, Basel, BS, Switzerland
[2] Novartis Healthcare Pvt Ltd, Hyderabad, Andhra Pradesh, India
[3] Novartis Pharmaceut UK Ltd, London, England
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE646
引用
收藏
页码：S183 / S183
页数：1
相关论文
共 50 条
  • [41] Enhancing immunoglobulin A nephropathy management: insights from the IGAN-MIC project
    Jiang, Gengru
    Chen, Qinkai
    Zhang, Qinghong
    Tean, M. A.
    Chen, Chaosheng
    Bi, Guangyu
    Xing, Changying
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [42] Systematic review of the healthcare cost of bronchopulmonary dysplasia
    Humayun, Jhangir
    Lofqvist, Chatarina
    Ley, David
    Hellstrom, Ann
    Gyllensten, Hanna
    BMJ OPEN, 2021, 11 (08):
  • [43] COST OF HEALTHCARE RESOURCE UTILIZATION IN INTERSTITIAL LUNG DISEASES IN GERMANY IN 2017
    Maqhuzu, P.
    Kreuter, M.
    Schwarzkopf, L.
    VALUE IN HEALTH, 2019, 22 : S845 - S845
  • [44] Healthcare Resource Utilization and the Cost of Care for Mucopolysaccharidosis I Patients in Iran
    Davari, Majid
    Nabizadeh, Azita
    Kadivar, Maliheh
    Asl, Akbar Abdollahi
    VALUE IN HEALTH REGIONAL ISSUES, 2019, 18 : 165 - 169
  • [45] Healthcare resource utilization and cost of obstructive hypertrophic cardiomyopathy in a US population
    Butzner, Michael
    Maron, Martin
    Sarocco, Phil
    Teng, Chia-Chen
    Stanek, Eric
    Tan, Hiangkiat
    Robertson, Laura
    AMERICAN HEART JOURNAL PLUS: CARDIOLOGY RESEARCH AND PRACTICE, 2022, 13
  • [46] DEVELOPMENT OF A DE NOVO MODEL TO ASSESS THE COST-EFFECTIVENESS OF A NEW TREATMENT OPTION FOR PATIENTS WITH PRIMARY IMMUNOGLOBULIN A NEPHROPATHY (IGAN)
    Davies, N.
    Dickinson, O.
    Downward, L.
    Pitcher, D.
    Gale, D.
    Ioannou, P.
    Kipentzoglou, K.
    Crabtree, M.
    VALUE IN HEALTH, 2023, 26 (12) : S73 - S74
  • [47] HEALTHCARE RESOURCE UTILIZATION AND COST BURDEN IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS
    Gish, R. G.
    MacEwan, J. P.
    Lebovitch, D.
    Nair, R.
    Wheeler, D.
    Li, J.
    Bessonova, L.
    VALUE IN HEALTH, 2024, 27 (06) : S149 - S149
  • [48] Healthcare resource utilization and payer cost analysis of patients with prurigo nodularis
    Huang, A. H.
    Canner, J. K.
    Williams, K. A.
    Grossberg, A. L.
    Kwatra, M. M.
    Kwatra, S. G.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (01) : 182 - 184
  • [49] Healthcare Resource Utilization and Cost of Invasive Meningococcal Disease in Ontario, Canada
    Rampakakis, Emmanouil
    Vaillancourt, Julie
    Mursleen, Sara
    Sampalis, John S.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2019, 38 (03) : 253 - 257
  • [50] Epidemiology and Healthcare Utilization in Patients With Gastroparesis: A Systematic Review
    Dilmaghani, Saam
    Zheng, Ting
    Camilleri, Michael
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (09) : 2239 - +
12345